{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:06:51Z","timestamp":1784549211643,"version":"3.55.0"},"reference-count":43,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of systemic metabolic dysfunction and has become one of the leading causes of chronic liver disease worldwide. Although obesity is a major determinant of MASLD, the metabolic and lifestyle context in which the disease develops may vary across different geographical and dietary environments. The present study aimed to evaluate the prevalence of MASLD among adults with metabolic dysfunction from two European cohorts, to compare the clinical, metabolic, lifestyle, and psychological characteristics of participants with MASLD from Romania and Italy, and to explore differences according to MASLD status within each cohort. In addition, intestinal permeability was exploratorily assessed in a subgroup of the Italian cohort. Methods: This prospective multicentre observational study included 132 adults undergoing metabolic and hepatic evaluation in Romania (n = 52) and Italy (n = 80). Hepatic steatosis was assessed using SteatoTest in the Romanian cohort and ultrasonography in the Italian cohort. Anthropometric and metabolic parameters were recorded in all participants. Dietary quality was evaluated using the MEDI-LITE questionnaire, physical activity using the International Physical Activity Questionnaire (IPAQ), depressive symptoms using the Patient Health Questionnaire-9 (PHQ-9), and health-related quality of life using the 36-Item Short Form Health Survey (SF-36). Intestinal permeability was evaluated in the Italian cohort using the lactulose\/mannitol absorption test. Results: MASLD was identified in 80.8% of participants from the Romanian cohort and in 66.3% of participants from the Italian cohort. Among patients with MASLD, Italian participants exhibited significantly higher body mass index, waist circumference, fasting insulin, total cholesterol, LDL cholesterol, and diastolic blood pressure compared with Romanian participants, whereas HDL cholesterol levels were significantly higher in the Romanian cohort. Sex-stratified analyses revealed significant sex-related differences in anthropometric and metabolic parameters within both cohorts. In both geographical populations, participants with MASLD demonstrated lower adherence to the Mediterranean diet, lower physical activity levels, higher depressive symptom burden, and less favorable quality-of-life indicators compared with participants without MASLD. Exploratory analyses of intestinal permeability in the Italian cohort did not reveal significant differences according to MASLD or obesity status. Conclusions: MASLD was highly prevalent in both Romanian and Italian adults with metabolic dysfunction. Patients with MASLD exhibited distinct metabolic and lifestyle profiles across the two geographical cohorts, supporting the potential contribution of environmental and lifestyle-related factors to MASLD heterogeneity. Lower adherence to the Mediterranean diet, reduced physical activity, and increased psychological burden were consistently associated with MASLD in both populations. Exploratory intestinal permeability analyses did not demonstrate significant differences according to MASLD or obesity status in the Italian cohort.<\/jats:p>","DOI":"10.3390\/medicina62071403","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:44:02Z","timestamp":1784544242000},"page":"1403","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic and Lifestyle Profiles of Metabolic Dysfunction-Associated Steatotic Liver Disease in Romanian and Italian Adults"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3405-4482","authenticated-orcid":false,"given":"Naomi-Adina","family":"Ciurea","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"},{"name":"Doctoral School of Medicine and Pharmacy, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Sciences and Technology of Targu Mures, 38 Gheorghe Marinescu Street, 540139 Targu Mures, Romania"},{"name":"Doctoral School of Public Health, Clinical Medicine and Oncology, University of Bari \u201cAldo Moro\u201d, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3711-2175","authenticated-orcid":false,"given":"Harshitha","family":"Shanmugam","sequence":"additional","affiliation":[{"name":"Clinica Medica \u201cA. Murri\u201d, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari Aldo Moro, Piazza G. Cesare, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Monica","family":"Pantea","sequence":"additional","affiliation":[{"name":"Department of Clinical Science-Internal Medicine, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-8591","authenticated-orcid":false,"given":"Paul","family":"Grama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-8262","authenticated-orcid":false,"given":"Irina-Bianca","family":"Kosovski","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-3850","authenticated-orcid":false,"given":"Simona","family":"Bataga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Di Ciaula","sequence":"additional","affiliation":[{"name":"Clinica Medica \u201cA. Murri\u201d, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari Aldo Moro, Piazza G. Cesare, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-1471","authenticated-orcid":false,"given":"Piero","family":"Portincasa","sequence":"additional","affiliation":[{"name":"Clinica Medica \u201cA. Murri\u201d, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari Aldo Moro, Piazza G. Cesare, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100375","DOI":"10.1016\/j.metop.2025.100375","article-title":"Obesity: Prevalence, Causes, Consequences, Management, Preventive Strategies and Future Research Directions","volume":"27","author":"Ahmed","year":"2025","journal-title":"Metab. Open"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11739-025-04090-3","article-title":"Tango between Obesogenic Environment and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Shifting towards Earlier Detection","volume":"20","author":"Shanmugam","year":"2025","journal-title":"Intern. Emerg. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e70132","DOI":"10.1002\/edm2.70132","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ciurea, N.-A., Pantea, C.M., Grama, P., Kosovski, I.-B., Farella, I., Bataga, S., Di Ciaula, A., and Portincasa, P. (2025). Ten-Year Atherosclerotic Cardiovascular Disease Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Separate Analyses from Romanian and Italian Cohorts Integrating Metabolic, Hepatic, and Gut\u2013Liver Axis Markers. J. Clin. Med., 14.","DOI":"10.3390\/jcm14238361"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","article-title":"Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"31","author":"Younossi","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s13679-025-00637-9","article-title":"Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression","volume":"14","author":"Koliaki","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s11739-025-03895-6","article-title":"Global Burden and Risk Factors of MASLD: Trends from 1990 to 2021 and Predictions to 2030","volume":"20","author":"Huang","year":"2025","journal-title":"Intern. Emerg. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Bojdo, K., Bulicz, A., Frankenstein, H., G\u0105sior, M., Kustosik, N., Rysz, J., and Franczyk, B. (2025). Obesity as a Multifactorial Chronic Disease: Molecular Mechanisms, Systemic Impact, and Emerging Digital Interventions. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47100787"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Choi, W., Woo, G.H., Kwon, T.-H., and Jeon, J.-H. (2025). Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199715"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Egresi, A., Kozma, B., Kar\u00e1csony, M., R\u00f3nasz\u00e9ki, A., Werling, K., Csongr\u00e1dy, B., Nov\u00e1k, P.K., Folhoffer, A., Szij\u00e1rt\u00f3, A., and Hagym\u00e1si, K. (2025). Cumulative Effect of Metabolic Factors on Hepatic Steatosis. Diagnostics, 15.","DOI":"10.3390\/diagnostics15182406"},{"key":"ref_11","unstructured":"Feingold, K.R., Adler, R.A., Ahmed, S.F., Anawalt, B., Blackman, M.R., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2000). Social and Environmental Factors Influencing Obesity. Endotext, MDText.com, Inc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12982-025-00818-w","article-title":"Dietary Strategies for Preventing and Managing Obesity through Evidence-Based Nutritional Interventions","volume":"22","author":"Aremu","year":"2025","journal-title":"Discov. Public Health"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Fatima, G., Dalmadi, I., S\u00fcll\u0151s, G., Tak\u00e1cs, K., and Halmy, E. (2025). Dietary Patterns for Health-Span and Longevity: A Comprehensive Review of Nutritional Strategies Promoting Lifelong Wellness. Appl. Sci., 15, Available online: https:\/\/www.mdpi.com\/2076-3417\/15\/22\/12013.","DOI":"10.3390\/app152212013"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Finicelli, M., Di Salle, A., Galderisi, U., and Peluso, G. (2022). The Mediterranean Diet: An Update of the Clinical Trials. Nutrients, 14.","DOI":"10.3390\/nu14142956"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Kim, S., Lee, Y., Kwon, Y.-J., and Lee, J.-W. (2024). Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis. Nutrients, 16.","DOI":"10.3390\/nu16203551"},{"key":"ref_16","unstructured":"(2026, March 09). Mediterranean Diet\u2014UNESCO Intangible Cultural Heritage. Available online: https:\/\/ich.unesco.org\/en\/RL\/mediterranean-diet-00884."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/09637486.2017.1287884","article-title":"Validation of a Literature-Based Adherence Score to Mediterranean Diet: The MEDI-LITE Score","volume":"68","author":"Sofi","year":"2017","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_18","unstructured":"(2026, March 09). Table 1 Values of Components of Adherence Score to the Mediterranean. Available online: https:\/\/www.researchgate.net\/figure\/alues-of-components-of-adherence-score-to-the-Mediterranean-diet-among-men-g-d_tbl1_259984734."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sheikh, M.Y., Younus, M.F., Shergill, A., and Hasan, M.N. (2025). Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199625"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2050312116671725","DOI":"10.1177\/2050312116671725","article-title":"SF-36 Total Score as a Single Measure of Health-Related Quality of Life: Scoping Review","volume":"4","author":"Lins","year":"2016","journal-title":"SAGE Open Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cheung, R.Y.M. (2025). Patient Health Questionnaire-9 (PHQ-9). Handbook of Assessment in Mindfulness Research, Springer.","DOI":"10.1007\/978-3-031-47219-0_63"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40618-017-0746-3","article-title":"Reproducibility and Validity of the Italian Version of the International Physical Activity Questionnaire in Obese and Diabetic Patients","volume":"41","author":"Minetto","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2012.12.032","article-title":"Gastrointestinal Permeability in Patients with Irritable Bowel Syndrome Assessed Using a Four Probe Permeability Solution","volume":"418","author":"Fourie","year":"2013","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101271","DOI":"10.1016\/j.jhepr.2024.101271","article-title":"Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease, 2010 to 2021","volume":"7","author":"Feng","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s41043-025-00973-5","article-title":"Epidemiological Trends and Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Middle East and North Africa Region: A 32-Year Analysis of Health Impact","volume":"44","author":"Sarkoohi","year":"2025","journal-title":"J. Health Popul. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2536759","DOI":"10.1080\/07853890.2025.2536759","article-title":"Global, Regional, and National Time Trends in Prevalence of Metabolic Dysfunction Associated Steatotic Liver Disease among Women of Reproductive Age: An Age-Period-Cohort Analysis for the Global Burden of Disease 2021 Study","volume":"57","author":"Wei","year":"2025","journal-title":"Ann. Med."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Dokova, K.G., Pancheva, R.Z., Usheva, N.V., Haralanova, G.A., Nikolova, S.P., Kostadinova, T.I., Egea Rodrigues, C., Singh, J., Illner, A.-K., and Aleksandrova, K. (2022). Nutrition Transition in Europe: East-West Dimensions in the Last 30 Years\u2014A Narrative Review. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.919112"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Portincasa, P., Khalil, M., Mahdi, L., Perniola, V., Idone, V., Graziani, A., Baffy, G., and Di Ciaula, A. (2024). Metabolic Dysfunction\u2013Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115640"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez, M., Boqu\u00e9, N., Bas, J.M.D., Mayneris-Perxachs, J., Arola, L., and Caimari, A. (2017). Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients, 9.","DOI":"10.3390\/nu9101052"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13435","article-title":"The Mediterranean Dietary Pattern as the Diet of Choice for Non-Alcoholic Fatty Liver Disease: Evidence and Plausible Mechanisms","volume":"37","author":"Salomone","year":"2017","journal-title":"Liver Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nutres.2023.09.005","article-title":"Adherence to a Mediterranean Diet May Improve Serum Adiponectin in Adults with Nonalcoholic Fatty Liver Disease: The MEDINA Randomized Controlled Trial","volume":"119","author":"Reddy","year":"2023","journal-title":"Nutr. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-145-1-200607040-00004","article-title":"Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors","volume":"145","author":"Estruch","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_33","unstructured":"(2026, May 25). Frontiers|Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Interplay of Gut Microbiome, Insulin Resistance, and Diabetes. Available online: https:\/\/www.frontiersin.org\/journals\/medicine\/articles\/10.3389\/fmed.2025.1618275\/full."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41574-022-00746-8","article-title":"The Multiple Roles of Life Stress in Metabolic Disorders","volume":"19","author":"Bartolomucci","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_35","first-page":"e84803","article-title":"Managing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the Digital Era: Overcoming Barriers to Lifestyle Change","volume":"17","author":"Kravchuk","year":"2025","journal-title":"Cureus"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Li, H., Konja, D., Wang, L., and Wang, Y. (2022). Sex Differences in Adiposity and Cardiovascular Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169338"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","article-title":"Visceral Adiposity and the Risk of Metabolic Syndrome Across Body Mass Index","volume":"7","author":"Shah","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ecl.2020.02.008","article-title":"Sex Differences in Adipose Tissue Function","volume":"49","author":"Gavin","year":"2020","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Gorini, S., Camajani, E., Feraco, A., Armani, A., Karav, S., Filardi, T., Aulisa, G., Cava, E., Strollo, R., and Padua, E. (2025). Exploring Gender Differences in the Effects of Diet and Physical Activity on Metabolic Parameters. Nutrients, 17.","DOI":"10.3390\/nu17020354"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116722","DOI":"10.1016\/j.intimp.2026.116722","article-title":"Decoding the Gut-Liver Crosstalk: Microbial Metabolite- Driven AhR Signalling Networks in MASLD Pathogenesis","volume":"180","author":"Song","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/mco2.70168","article-title":"Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhou, J., Zhu, B., Bing, Z., Wang, T., and Zhao, Y. (2026). The Gut\u2013Liver Axis in MASLD: From Host\u2013Microbiome Crosstalk to Precision Therapeutics. Microorganisms, 14.","DOI":"10.3390\/microorganisms14020471"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the Barriers: The Role of Gut Homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)","volume":"16","author":"Cubero","year":"2024","journal-title":"Gut Microbes"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:30:46Z","timestamp":1784547046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071403"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071403","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}